Latest Trials Latest NewsFAQ

University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Genetics of Response to Canagliflozin

Phase 1

Active, not recruiting

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Canagliflozin

First Posted Date: 2016-09-08

Last Posted Date: 2024-11-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 700

Registration Number: NCT02891954

Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598)

Phase 2

Withdrawn

Conditions: Metastatic Pancreas Cancer

Interventions: Drug: Durvalumab
Radiation: Radiation Therapy

First Posted Date: 2016-08-31

Last Posted Date: 2019-09-12

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT02885727

Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD

Phase 3

Completed

Conditions: Alcohol Use Disorder
PTSD

Interventions: Drug: Pregabalin plus BBCET
Other: Placebo plus BBCET

First Posted Date: 2016-08-31

Last Posted Date: 2024-03-13

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 57

Registration Number: NCT02884908

Locations: 🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States

Maraviroc Efficacy for Hepatitis C

Phase 4

Completed

Conditions: Hepatitis C
Human Immunodeficiency Virus

Interventions: Drug: Maraviroc

First Posted Date: 2016-08-29

Last Posted Date: 2024-05-01

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 10

Registration Number: NCT02881762

Locations: 🇺🇸
Institute of Human Virology at the University of Maryland School of Medicine, Baltimore, Maryland, United States

Decitabine and Talazoparib in Untreated AML and R/R AML

Phase 1

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Decitabine
Drug: talazoparib

First Posted Date: 2016-08-25

Last Posted Date: 2023-03-29

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 25

Registration Number: NCT02878785

Locations: 🇺🇸
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States

Improving Cardiometabolic Health of Youth on Antipsychotic Medication

Not Applicable

Completed

Conditions: Childhood Obesity

Interventions: Behavioral: Treatment
Behavioral: Control

First Posted Date: 2016-08-24

Last Posted Date: 2022-10-13

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 302

Registration Number: NCT02877823

Adolescent to Adult Patient-centered HIV Transition (ADAPT) Study

Not Applicable

Completed

Conditions: AIDS
HIV

Interventions: Other: PEPFAR Enhanced Standard of Care (PESCA)
Behavioral: Peer Transition Advocate (PTA)

First Posted Date: 2016-08-19

Last Posted Date: 2023-12-22

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 298

Registration Number: NCT02872805

Locations: 🇳🇬
Institute of Human Virology, Nigeria, Abuja, FCT, Nigeria

Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.

Not Applicable

Terminated

Conditions: Anxiety
Suicide
Insomnia
Agitation
Depression

Interventions: Device: Alpha-Stim®.
Behavioral: Montgomery-Åsberg Depression Rating Scale, Hamilton Anxiety Rating Scale, The Pittsburgh Sleep Quality Index and agitated behavior Scale

First Posted Date: 2016-07-27

Last Posted Date: 2019-12-26

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 30

Registration Number: NCT02846740

Locations: 🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States

Alpha as a Predictive Biomarker

Not Applicable

Completed

Conditions: Pain

Interventions: Other: Painful Stimuli

First Posted Date: 2016-06-13

Last Posted Date: 2021-08-11

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 80

Registration Number: NCT02796625

Locations: 🇺🇸
University of Maryland School of Dentistry, Baltimore, Maryland, United States

Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing

Phase 2

Completed

Conditions: Fracture

Interventions: Drug: Vitamin D3
Other: Placebo

First Posted Date: 2016-06-01

Last Posted Date: 2022-03-31

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 102

Registration Number: NCT02786498

Locations: 🇺🇸
University of Maryland, R Adams Cowley Shock Trauma Center, Baltimore, Maryland, United States
🇨🇦
McMaster University, Center for Evidence-Based Orthopaedics, Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy